Navigation Links
Concomitant use of Perforomist & tiotropium -- significant improvements -- COPD
Date:5/20/2008

Shortness of breath, chest tightness, nighttime awakenings, and total symptom scores all improved significantly with the Perforomist/TIO treatment compared with TIO/placebo (p<0.05). Cough scores did not differ between groups. Albuterol use declined in the Perforomist/TIO group from 2.4 to1.3 puffs/day and increased in the TIO/placebo group from 2.8 to 3.4 puffs/day over six weeks; another statistically significant difference (p< 0.0001). SGRQ total scores did not change markedly from baseline or differ between groups except for the symptom domain score, which was superior in the Perforomist/TIO group compared to TIO/placebo (-6.3, p<0.04).

DEY is very pleased with the results of this study and the benefit that patients are seeing with Perforomist Inhalation Solution, said Carolyn Myers, Ph.D., President of Dey, L.P. We wish to thank Dr. Tashkin and the other members of the research team for their careful investigation into the clinical benefits of concomitant therapy of Perforomist and tiotropium. At DEY, we are committed to developing effective new treatments for serious and complex diseases, and with Perforomist are proud to provide physicians and patients a twice-daily COPD maintenance medication that offers the flexibility of dosing via nebulization.

For those attending ATS 2008, the presentation is available as follows:

Poster viewing: Session ID C42 COPD Pharmacotherapy I: Effects of Bronchodilators Tuesday, May 20, 2008, 10:45 a.m. 12:30 p.m. EDT Metro Toronto Convention Center; Area F: Halls A-B North Building, Level 300

Poster # F4: Addition of Nebulized Formoterol Fumarate to Tiotropium Treatment Relieves Dyspnea and Symptoms in COPD Patients


'/>"/>

Contact: Amy Techtmann
amy.techtmann@fkhealth.com
617-761-6784
Feinstein Kean Healthcare
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Concomitant treatment with nebulized formoterol fumarate & tio-significant improvements -- COPD
2. Clinical trial data: Safety/efficacy of concomitant formoterol fumarate/tiotropium treating COPD
3. Perforomist-comparable pharmacokinetic and pharmacodynamic profile to DPI formulation
4. Clinical Trial Data for Perforomist(TM) Inhalation Solution to be Presented at ATS on May 20, 2008
5. International Diabetes Federation gives grant to diabetes screening & prevention program in Vietnam
6. Riley Hospital for Children & Capital Institute of Pediatrics become international sister hospitals
7. IU Health & Wellness: New research findings from the Kinsey Institute
8. European Society of Human Reproduction & Embryology 24th annual meeting
9. Genetic Engineering & Biotechnology News reports on clinical trials in developing countries
10. IU Health & Wellness: Research and insights from Indiana University
11. Congressional R&D Caucus co-chairs join scientists, engineers and graduate students
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... NC (PRWEB) , ... August 03, 2015 , ... The ... by experience. Learning from her grandmother’s side at a young age, Nasreen Zereshki was ... Zereshki has decided to share her cookbook Recipes from My Persian Kitchen with the ...
(Date:8/3/2015)... Asbury Park, NJ (PRWEB) , ... August 03, ... ... is pleased to announce the development of it’s new program “Designing Secure Healthcare ... provide software architects, engineers and technology leaders from healthcare organizations with access to ...
(Date:8/3/2015)... (PRWEB) , ... August 03, 2015 , ... A July ... among U.S. emergency rooms in recent years, according to the American Dental Association. According ... of dental emergency visits went from 1.1 million in a single year to 2.2 ...
(Date:8/3/2015)... ... 2015 , ... Illinois Health & Science (IHS) has completed the purchase of ... all of IBAM NA’s cyclotron sites and research and development facilities. , ... as well as a large manufacturing hub in Noblesville, Indiana,” said Ken Smithmier, President ...
(Date:8/3/2015)... Miami, Florida (PRWEB) , ... August 03, 2015 , ... ... neuropathy pain accompanied by tissue injury caused by diabetes after many years of suffering ... work many times, and he didn’t want to ask for extra time off or ...
Breaking Medicine News(10 mins):Health News:Persian Cuisine: Colorful and Extremely Healthy 2Health News:Sensato and Divurgent are pleased to announce the development of it’s new program “Designing Secure Healthcare Systems” 2Health News:Sensato and Divurgent are pleased to announce the development of it’s new program “Designing Secure Healthcare Systems” 3Health News:Sensato and Divurgent are pleased to announce the development of it’s new program “Designing Secure Healthcare Systems” 4Health News:Los Angeles Periodontists Comment on Rising Dental Emergency Room Trips 2Health News:Los Angeles Periodontists Comment on Rising Dental Emergency Room Trips 3Health News:Illinois Health & Science Expands Nuclear Medicine Footprint With Purchase of IBA Molecular North America, Inc. 2Health News:Chinese Health Care Provider Heshoutang Now Give Patients Complimentary Online Healing Options 2Health News:Chinese Health Care Provider Heshoutang Now Give Patients Complimentary Online Healing Options 3
... June 9 Par Pharmaceutical Companies, Inc. (NYSE: ... spray to the trade. Calcitonin-salmon nasal spray is a ... sales of Miacalcin were approximately $112 million in 2008, according ... Important information about calcitonin-salmon nasal spray , , ...
... Offers One Stop for Market-Specific Managed Care Enrollment ... and Health Plan Trends , , NASHVILLE, ... managed care market intelligence, reports that commercial pharmacy ... the state level than commercial medical benefit enrollment. ...
... solid reputation within industry , , HOFFMAN ESTATES, ... Spine, Inc. announced today that it has appointed Todd P. ... Fanning has held senior sales and marketing positions at well ... orthopaedic industries, including Spinal Concepts (now part of Zimmer ...
... Selected as Best EHR/PM System to Help Physicians, Organization ... , , DALLAS, June 9 ... software solutions for physician practices, announced today that after ... Physicians, Organization of the University Medical Center ...
... Cyrus at the 20th Annual A Time For Heroes Family ... AIDS Foundation , , LOS ANGELES, June 9 ... 20th annual A Time For Heroes Family Picnic, held June ... Pediatric AIDS Foundation. More than 80 of Hollywood,s best-known names ...
... Kennedy On Some Points, Denise Gott Agrees that Everyone ... Acute Ones , , KIRKLAND, Wash., June 9 ... terms with a Democratic Congress on health reform, according ... praise on Senator Edward Kennedy (D-MA) for his crusading ...
Cached Medicine News:Health News:Par Pharmaceutical Begins Shipment of Generic Miacalcin(R) 2Health News:Commercial Pharmacy Benefit Enrollment Experiencing Greater Shifts in Florida than Commercial Medical Benefit Enrollment 2Health News:The Physicians' Organization of the University Medical Center at Princeton Chooses iMedica's EHR and Practice Management Solutions 2Health News:The Physicians' Organization of the University Medical Center at Princeton Chooses iMedica's EHR and Practice Management Solutions 3Health News:Celebrities Come Together to Fight Pediatric AIDS 2Health News:Celebrities Come Together to Fight Pediatric AIDS 3Health News:Insurance Leader Praises Senator Kennedy for Promoting Long-Term Care Aid for All Americans as Part of Health Reform 2Health News:Insurance Leader Praises Senator Kennedy for Promoting Long-Term Care Aid for All Americans as Part of Health Reform 3Health News:Insurance Leader Praises Senator Kennedy for Promoting Long-Term Care Aid for All Americans as Part of Health Reform 4
(Date:8/3/2015)... -- Encision Inc. (PK:ECIA), a medical device company owning patented ... minimally invasive surgery, today announced financial results for its ... The Company posted quarterly net revenue of ... thousand, or $(0.02) per share. These results compare to ... of $202 thousand, or $(0.02) per share, in the ...
(Date:8/2/2015)... , Aug. 3, 2015  Isis Pharmaceuticals, Inc. ... a strategic collaboration to discover and develop antisense ... new collaboration builds on a broad existing relationship ... approach in these therapeutic areas using novel RNA-targeted ... use of its antisense technology to diseases of ...
(Date:7/31/2015)... N.C. , July 31, 2015  In today,s ... customers who are increasingly mobile, increasingly connected, and increasingly ... growing variety of customer interaction channels and tools is ... including social media. According to research ... over the counter (OTC) segment in a call center ...
Breaking Medicine Technology:Encision Reports First Quarter Fiscal Year 2016 Results 2Encision Reports First Quarter Fiscal Year 2016 Results 3Encision Reports First Quarter Fiscal Year 2016 Results 4Encision Reports First Quarter Fiscal Year 2016 Results 5AstraZeneca and Isis Pharmaceuticals to Discover and Develop Antisense Drugs for Cardiovascular, Metabolic and Renal Diseases 2AstraZeneca and Isis Pharmaceuticals to Discover and Develop Antisense Drugs for Cardiovascular, Metabolic and Renal Diseases 3AstraZeneca and Isis Pharmaceuticals to Discover and Develop Antisense Drugs for Cardiovascular, Metabolic and Renal Diseases 4Best Practices in Building World-Class Consumer & Over-the-Counter Call Centers 2
... Wash., Oct. 21, 2011 Evergreen Healthcare today announced ... Care Excellence Awards for 2012 from HealthGrades, placing it ... its superior patient outcomes and significantly reduced mortality rates ... the third consecutive year, Evergreen was honored with HealthGrades, ...
... Fla., Oct. 21, 2011 Boca Pharmacal, Inc., today announced ... Abbreviated New Drug Application (ANDA) for Glycopyrrolate Tablets USP, 1 ... 1 mg and Robinul Forte Tablets, 2 mg, distributed by ... adjunctive therapy in the treatment of peptic ulcers. ...
Cached Medicine Technology:Evergreen Named One of America's 100 Best Hospitals for Stroke Care 2Evergreen Named One of America's 100 Best Hospitals for Stroke Care 3Boca Pharmacal Receives FDA Approval on Glycopyrrolate Tablets 2
... catheter is a coaxial, ... is made of PEBAX ... in the inner balloon ... markings enhance the visibility ...
For support, strength and control in your interventions, the RunWay Guide Catheter's large lumen and high-performance design represents a new era in guide catheters....
For support, strength and control in your interventions, the RunWay Guide Catheter's large lumen and high-performance design represents a new era in guide catheters....
... 20-year history, the VOYAGER RX Dilatation Catheter ... outcomes. It combines a new low profile, ... shaft,more flexible markers, and short taper balloon ... tortuous anatomy with even greater confidence, opening ...
Medicine Products: